|
See related Flexbumin infusion information |
|
|
|
Manufacturer |
Baxter Healthcare |
|
Distributor |
Zuellig |
|
Contents |
Human albumin |
|
Indications |
Hypovolemia, cardiopulmonary bypass surgery, hemolytic disease of the newborn. Hypoalbuminemia due to burns, adult resp distress syndrome, nephrosis. |
|
Dosage |
Individualized dosage. Administer IV at a max rate of 1 mL/min. Hypovolemic shock Adult Initially 100-200 mL. Childn Initially 2.5-5 mL/kg body wt. Repeat after 15-30 min if response is inadequate. Hypoalbuminemia Max daily dose: 2 g/kg body wt. Hemolytic disease of the newborn 1 g/kg body wt prior to or during exchange transfusion. |
|
Contraindications |
History of allergic reaction to albumin; severely anemic patients; cardiac failure. |
|
Special Precautions |
A BP rise after infusion may require close observation of the injured or post-op patient to detect & treat severed blood vessels that may not have bled at a lower BP. Pregnancy. |
|
Adverse Drug Reactions |
Occasionally nausea, fever, chills or urticaria.
View ADR Monitoring Form |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Flexbumin infusion |
|
Flexbumin (bag) 20 % x 50 mL |
|
Flexbumin (bag) 25 % x 50 mL |
|
|
|
Manufacturer: |
Baxter Healthcare |
|
Distributor: |
Zuellig
|
|
|
|
